Camp4 Therapeutics (CAMP) Operating Leases (2023 - 2026)

Camp4 Therapeutics has reported Operating Leases for 4 years, with the latest figure at $1.7 million in Q1 2026.

• Quarterly Operating Leases fell 63.02% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 63.02% YoY) and the FY2025 annual result came in at $1.7 million, down 69.27% from the prior year.
• Operating Leases improved to $1.7 million in Q1 2026 per CAMP's latest filing, from $1.7 million in the prior quarter.
• Over five years, Operating Leases peaked at $8.5 million in Q4 2023 and troughed at $1.7 million in Q4 2025.
• A 4-year average of $4.8 million and a median of $5.1 million in 2024 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2024 and 2025: Operating Leases sank 35.28% in 2024, then sank 69.27% in 2025.
• Over 4 years, Operating Leases stood at $8.5 million in 2023, then plunged by 35.28% to $5.5 million in 2024, then tumbled by 69.27% to $1.7 million in 2025, then grew by 2.96% to $1.7 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $1.7 million, $1.7 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.